Vulnerability Description
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
CVSS Score
8.8
HIGH
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Sas | Sas Drug Development | < 32drg02 |
Related Weaknesses (CWE)
References
- http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DVendor Advisory
- http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DVendor Advisory
FAQ
What is CVE-2007-6763?
CVE-2007-6763 is a vulnerability with a CVSS score of 8.8 (HIGH). SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
How severe is CVE-2007-6763?
CVE-2007-6763 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2007-6763?
Check the references section above for vendor advisories and patch information. Affected products include: Sas Sas Drug Development.